BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8797573)

  • 1. Reduced DNA repair capacity in lung cancer patients.
    Wei Q; Cheng L; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(18):4103-7. PubMed ID: 8797573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
    Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
    Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced DNA repair capacity in head and neck cancer patients.
    Cheng L; Eicher SA; Guo Z; Hong WK; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):465-8. PubMed ID: 9641488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
    Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
    Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
    Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
    Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
    Spitz MR; Wu X; Wang Y; Wang LE; Shete S; Amos CI; Guo Z; Lei L; Mohrenweiser H; Wei Q
    Cancer Res; 2001 Feb; 61(4):1354-7. PubMed ID: 11245433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma.
    Wang L; Wei Q; Shi Q; Guo Z; Qiao Y; Spitz MR
    Carcinogenesis; 2007 Jul; 28(7):1430-6. PubMed ID: 17341660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals.
    D'Errico M; Calcagnile A; Iavarone I; Sera F; Baliva G; Chinni LM; Corona R; Pasquini P; Dogliotti E
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):553-9. PubMed ID: 10385147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
    Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
    Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
    Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
    Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study.
    Xiong P; Bondy ML; Li D; Shen H; Wang LE; Singletary SE; Spitz MR; Wei Q
    Cancer Res; 2001 Dec; 61(23):8465-9. PubMed ID: 11731429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression.
    Wang LE; Li C; Strom SS; Goldberg LH; Brewster A; Guo Z; Qiao Y; Clayman GL; Lee JJ; El-Naggar AK; Prieto VG; Duvic M; Lippman SM; Weber RS; Kripke ML; Wei Q
    Clin Cancer Res; 2007 Nov; 13(21):6532-9. PubMed ID: 17975167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer.
    Shen H; Spitz MR; Qiao Y; Guo Z; Wang LE; Bosken CH; Amos CI; Wei Q
    Int J Cancer; 2003 Oct; 107(1):84-8. PubMed ID: 12925960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk.
    Mahabir S; Forman MR; Barerra SL; Dong YQ; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2756-62. PubMed ID: 18086784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair related to multiple skin cancers and drug use.
    Wei Q; Matanoski GM; Farmer ER; Hedayati MA; Grossman L
    Cancer Res; 1994 Jan; 54(2):437-40. PubMed ID: 8275480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer.
    Lin J; Kadlubar FF; Spitz MR; Zhao H; Wu X
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1832-6. PubMed ID: 16030125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
    Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
    Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
    Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
    Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.